Skip to main content

Omnes Capital — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

61
Companies
$1.8B
Total invested
$33.5M
Avg. check
55
Industries
Biotechnology 9Software 6Artificial Intelligence (AI) 6Pharmaceutical 3Life Science 3Health Care 3+49 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 61
AlgoTherapeutix
March 2023

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

Biotechnology · Suresnes$21.5M Series B
Coave Therapeutics
January 2025

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Biotechnology · Paris$32.9M Series A
Opensee
December 2022

Opensee is an AI-powered data platform for financial institutions that provides interactive data, analytics, and reporting services.

Agentic AI · Paris$11.7M Series A
Planet A Foods
November 2025

Planet A Foods is a B2B sustainable ingredients company that specializes in the production of cocoa-free chocolate.

Food and Beverage · MunichCorporate Round
Dust Mobile
November 2022

Dust Mobile provides private and secure mobile communications locally and globally.

Communication Hardware · Brussels$12.4M Series B
Ilmatar
November 2023

Ilmatar is a project-oriented integrator in the field of renewable energy production.

Energy · Helsinki$543.9M Debt Financing
Capsule Labs
October 2022

Capsule Labs is a technology solutions provider that facilitates digital asset transmission and the creation of utility NFTs.

Blockchain · Biarritz$4.7M Seed
Jimmy
March 2026

Jimmy develops and operates thermal generators that supply industrial facilities with process heat produced through nuclear fission.

Energy · Paris$46.5M Grant
ARX Robotics
July 2025

ARX Robotics is a defense startup that develops autonomous unmanned ground systems for military and civilian applications.

Artificial Intelligence (AI) · München$12.7M Series A
Skynopy
June 2025

Skynopy is a space technology company that provides satellite communication through a hybrid network of ground antennas.

Mobile · Paris$17.7M Series Unknown
ENTEROME
June 2025

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Biopharma · Paris$19.0M Series Unknown
SeqOne Genomics
May 2025

SeqOne is a next generation genomic analysis for next generation healthcare.

Analytics · Montpellier$22.6M Series Unknown
Sekoia.io
April 2025

Sekoia.io is an intelligence driven SOC platform that enables security analysts to detect & respond threats in real time

Artificial Intelligence (AI) · Rennes$28.5M Series B
Iktos
February 2025

Iktos is a deep learning technology platform focused on new drug design and discovery.

Artificial Intelligence (AI) · Paris$2.6M Grant
Qantev
September 2024

AI claims platform for health & life insurance

Artificial Intelligence (AI) · Paris$33.5M Series B
Unseenlabs
February 2024

Unseenlabs offers maritime surveillance via space-based RF detection, tracking ships worldwide by electromagnetic signatures.

Aerospace · Rennes$92.2M Series C
GEEV
February 2024

GEEV is a collaborative mobile app that allows its members to donate unused stuff or surplus food, and others to get them for free!

Communities · Bordeaux$4.9M Series Unknown
Corteria Pharmaceuticals
September 2023

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

Biotechnology · Paris$69.5M Series A
PeopleSpheres
September 2023

PeopleSpheres is to bringing you the future of HR NOW, through their best-in-class HR Platform as a Services (PaaS).

Human Resources · Montpellier$536K Equity Crowdfunding
DiogenX
May 2023

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

Biotechnology · Marseille$36.8M Series A
Ternoa
September 2022

Ternoa offers Blockchain technology to transfer data securely, anonymously, and without alienation nor intermediaries.

Apps · Biarritz$7.3M Seed
WhiteLab Genomics
September 2022

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

Artificial Intelligence (AI) · Paris$10.0M Seed
Qubit Pharmaceuticals
June 2022

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

Biotechnology · Paris$16.9M Seed
Therapixel
May 2022

Therapixel is a software company specialized in artificial intelligence for medical imaging analysis

Artificial Intelligence (AI) · Nice$15.6M Series B

Where Omnes Capital invests

Biotechnology9
Software6
Artificial Intelligence (AI)6
Pharmaceutical3
Life Science3
Health Care3

About Omnes Capital's portfolio

How many companies has Omnes Capital invested in?▸

Omnes Capital has invested in 61 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Omnes Capital invest in?▸

Omnes Capital's top investment sectors include Biotechnology, Software, Artificial Intelligence (AI), Pharmaceutical, Life Science. The firm invests across 55 different industry categories.

What is Omnes Capital's largest investment?▸

Among tracked funding rounds, Ilmatar received $543.9M in a Debt Financing round. Omnes Capital's total known invested capital is $1.8B.

What is the average investment size for Omnes Capital?▸

Omnes Capital's average investment size is $33.5M across its portfolio of 61 companies.

What are Omnes Capital's most recent investments?▸

Recent Omnes Capital portfolio additions include AlgoTherapeutix, Coave Therapeutics, Opensee, Planet A Foods, Dust Mobile. These companies were founded in 2020 or later.

Reach the founders behind these 61 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →